These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22967665)

  • 21. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
    de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregnancy and early-stage melanoma.
    Daryanani D; Plukker JT; De Hullu JA; Kuiper H; Nap RE; Hoekstra HJ
    Cancer; 2003 May; 97(9):2248-53. PubMed ID: 12712479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.
    Rossi CR; De Salvo GL; Bonandini E; Mocellin S; Foletto M; Pasquali S; Pilati P; Lise M; Nitti D; Rizzo E; Montesco MC
    Ann Surg Oncol; 2008 Apr; 15(4):1202-10. PubMed ID: 18165880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of unfavorable presentation of primary cutaneous melanoma.
    Fallah M; Kharazmi E; Thomsen H; Sundquist J; Hemminki K
    J Am Acad Dermatol; 2011 Jul; 65(1):e5-6. PubMed ID: 21679807
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical impact of biopsy method on the quality of surgical management in melanoma.
    Kaiser S; Vassell R; Pinckney RG; Holmes TE; James TA
    J Surg Oncol; 2014 Jun; 109(8):775-9. PubMed ID: 24862925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sentinel node biopsy as a prognostic factor in cutaneous melanoma].
    Avilés-Izquierdo JA; Lázaro-Ochaita P
    Actas Dermosifiliogr; 2009; 100(6):486-92. PubMed ID: 19709553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A population-based validation of the American Joint Committee on Cancer melanoma staging system.
    Gimotty PA; Botbyl J; Soong SJ; Guerry D
    J Clin Oncol; 2005 Nov; 23(31):8065-75. PubMed ID: 16258105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of thorough block sampling in the histologic evaluation of melanomas.
    Dyson SW; Bass J; Pomeranz J; Jaworsky C; Sigel J; Somach S
    Arch Dermatol; 2005 Jun; 141(6):734-6. PubMed ID: 15967919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating invasive cutaneous melanoma: is the initial biopsy representative of the final depth?
    Ng PC; Barzilai DA; Ismail SA; Averitte RL; Gilliam AC
    J Am Acad Dermatol; 2003 Mar; 48(3):420-4. PubMed ID: 12637923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma.
    Fisher NM; Schaffer JV; Berwick M; Bolognia JL
    J Am Acad Dermatol; 2005 Sep; 53(3):393-406. PubMed ID: 16112344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic study of 85 cases of melanoma of the female genitalia.
    Tcheung WJ; Selim MA; Herndon JE; Abernethy AP; Nelson KC
    J Am Acad Dermatol; 2012 Oct; 67(4):598-605. PubMed ID: 22243767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nail apparatus melanoma: A comparative, clinicoprognostic study of the initial clinical and morphological characteristics of 49 patients.
    Lee WJ; Lee JH; Won CH; Chang SE; Choi JH; Moon KC; Lee MW
    J Am Acad Dermatol; 2015 Aug; 73(2):213-20. PubMed ID: 26028523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An objective measure of growth rate using partial biopsy specimens of melanomas that were initially misdiagnosed.
    Lin MJ; Mar V; McLean C; Kelly JW
    J Am Acad Dermatol; 2014 Oct; 71(4):691-7. PubMed ID: 24976443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes.
    Zogakis TG; Essner R; Wang HJ; Foshag LJ; Morton DL
    Ann Surg Oncol; 2007 May; 14(5):1604-11. PubMed ID: 17333418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sarcopenia as a prognostic factor among patients with stage III melanoma.
    Sabel MS; Lee J; Cai S; Englesbe MJ; Holcombe S; Wang S
    Ann Surg Oncol; 2011 Dec; 18(13):3579-85. PubMed ID: 21822551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma?
    Gajdos C; Griffith KA; Wong SL; Johnson TM; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
    Cancer; 2009 Dec; 115(24):5752-60. PubMed ID: 19827151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
    Azimi F; Scolyer RA; Rumcheva P; Moncrieff M; Murali R; McCarthy SW; Saw RP; Thompson JF
    J Clin Oncol; 2012 Jul; 30(21):2678-83. PubMed ID: 22711850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.